Efficacy of lopinavir–ritonavir combination therapy for the treatment of hospitalized COVID-19 patients: a meta-analysisMeta-Analysis Published on 2022-01-312022-10-31 Journal: Future Virology [Category] COVID-19, [키워드] adverse events Antiviral benefit body temperature Clinical use combination therapy control group COVID-19 demonstrated Efficacy Efficacy and safety evaluate hospitalized COVID-19 hospitalized COVID-19 patient hospitalized COVID-19 patients incidence lack Lopinavir Lopinavir–ritonavir material mechanical ventilation meta-analyses Meta-analysis Mortality observational study outcome outcomes Randomized Ritonavir SARS-CoV-2 SARS-CoV-2 test significant increase therapy Treatment [DOI] 10.2217/fvl-2021-0066 PMC 바로가기 [Article Type] Meta-Analysis
The Role of Ionizing Radiation for Diagnosis and Treatment against COVID-19: Evidence and ConsiderationsReview Published on 2022-01-292022-10-31 Journal: Cells [Category] COVID-19, SARS, [키워드] alleviate Anti-inflammatory effects anti-inflammatory treatment Cancer cardiac disease Chest CT Clinical use Computed tomography Coronavirus disease 2019 COVID-19 COVID-19 patient deaths decrease diagnostic effective Evidence health worker healthcare identify imaging ionizing radiation life-threatening low dose low dose radiation therapy (LDRT) management pandemic patients Pneumonia Radiation radiation therapy Radiotherapy risk role Spread Symptom the disease treat Treatment [DOI] 10.3390/cells11030467 PMC 바로가기 [Article Type] Review
mRNA booster immunization elicits potent neutralizing serum activity against the SARS-CoV-2 Omicron variantmRNA 부스터 면역화는 SARS-CoV-2 오미크론 변이체에 대한 강력한 중화 혈청 활성을 유도합니다Brief Communication Published on 2022-01-192022-09-10 Journal: Nature Medicine [Category] MERS, SARS, 변종, 진단, [키워드] antibodies BNT162b2 booster Booster vaccine both groups Clinical use Cohort convalescent individual convalescent individuals COVID-19 vaccine dose elicit epitope Epitopes globe glycoprotein humoral immune response immune evasion immunization IMPROVE in both group individual Infection lack monoclonal antibodies monoclonal antibody mRNA Mutation neutralization Neutralizing Neutralizing activity Neutralizing antibodies neutralizing antibody neutralizing capacity omicron Omicron variant polyclonal sera Pseudovirus neutralization assays rapid increase recipient recipients SARS-CoV-2 sera serum serum neutralizing capacity significant increase spike glycoprotein the SARS-CoV-2 Vaccines variant variant of SARS-CoV-2 Viral viral spike [DOI] 10.1038/s41591-021-01676-0 PMC 바로가기 [Article Type] Brief Communication
Ketogenic diet for human diseases: the underlying mechanisms and potential for clinical implementationsReview Article Published on 2022-01-172022-10-04 Journal: Signal Transduction and Targeted Therapy [Category] 바이오마커, [키워드] approach cellular and molecular clinical evidence Clinical use conducted different diseases Diseases Efficacy and safety epilepsy Evidence Health policy implementation increasingly induce intractable ketogenic Ketogenic diet malignancies mechanism mechanisms Metabolic disorders metabolism obesity Randomized controlled trial regimen Research spectrum of disease subject therapeutic effect therapeutic potential Treatment [DOI] 10.1038/s41392-021-00831-w PMC 바로가기 [Article Type] Review Article
A Comparative and Comprehensive Review of Antibody Applications in the Treatment of Lung DiseaseReview Published on 2022-01-172022-10-29 Journal: International Review of Cell and Molecular Biology [Category] COVID-19, [키워드] ACE2 protein addition antibodies antibody Antigen application Autoimmune disease B cell benefit bioinformatics Cancer cancer patient Cancer patients Clinical use Comparative Comprehensive connection COVID-19 CTLA-4 cytokine debatable disease Diseases explain IL-1β IL-6 immune Immunotherapy Infectious disease mechanism monoclonal antibody neutralizing antibody Patient PD-L1 potential mechanism produced Protein provided review signaling pathway somatic cells subsequent therapeutic effect therapy Treatment tyrosine Vaccine VEGF virus entry [DOI] 10.3390/life12010130 PMC 바로가기 [Article Type] Review
BPC 157 as Potential Treatment for COVID-19Research article Published on 2022-01-012022-10-05 Journal: Medical Hypotheses [Category] 임상, 치료법, [키워드] activated acute respiratory distress animal model Anti-inflammatory BPC 157 cardiovascular complications caused China Clinical management clinical trial Clinical use Comorbidity complementary Complication coronavirus disease Course COVID-19 COVID-19 patient Critical Cytoprotection demonstrated Effect effective endothelial Endothelial cell Endothelial cells (ECs) Endothelial nitric oxide synthase (eNOS) examined explain functions Human immune response IMPROVE Liver damage multi-organ failure neurological nitric oxide organ injury organ system outbreak patients peptide Potential proinflammatory Prophylactic provoke reduced syndrome the disease thrombotic tissue repair Treatment Vascular vascular disease [DOI] 10.1016/j.mehy.2021.110736 [Article Type] Research article
Performance of a high-throughput, automated enzyme immunoassay for the detection of SARS-CoV-2 antigen, including in viral “variants of concern”: Implications for clinical use바이러스 "관심 있는 변이체"를 포함하여 SARS-CoV-2 항원 검출을 위한 고처리량 자동화 효소 면역분석의 성능: 임상 사용에 대한 시사점Article Published on 2022-01-012022-09-11 Journal: Journal of Clinical Virology [Category] SARS, 변종, 치료기술, [키워드] alternative Antigen antigen test automated Clinical use Cohort cohorts of patients collected complement diagnostic Direct EIA enzyme enzyme immunoassay Epidemic epidemiological evaluated French immunoassay in viral Laboratory NPs NPSs nucleic acid nucleic acid testing Patient performance positive provided reported retrospective cohort RT-PCR SARS CoV SARS CoV-2 SARS-CoV-2 SARS-CoV-2 antigen SARS-CoV-2 RNA SARS-CoV-2 viral second wave sensitivities sensitivity specificity subject subjects Support tested thresholds variant variants variants of concern viral antigens [DOI] 10.1016/j.jcv.2021.105048 PMC 바로가기 [Article Type] Article
Persistent SARS-CoV-2 infection in patients with secondary antibody deficiency: successful clearance following combination casirivimab and imdevimab (REGN-COV2) monoclonal antibody therapy2 차 항체 결핍 환자의 지속적인 SARS-COV-2 감염 : Casirivimab 및 Imdevimab (Regn-Cov2) 모노클로 날 항체 요법에 따른 성공적인 통관Case Reports Published on 2021-12-302022-09-01 Journal: Annals of Clinical Microbiology and Antimicrobials [Category] SARS, 변종, 진단, 치료기술, [키워드] accompanied administration antibody Antibody deficiency Antibody Response Antibody responses antiviral therapy B cell B cell depleting therapy benefit Case report case reports Casirivimab Chronic COVID-19 Chronic lymphocytic leukaemia clearance Clinical improvement clinical recovery clinical response clinical study Clinical use Combination convalescent plasma deficiency delivery depleting ecological ecological niche Effectiveness evade Evidence Evolution failure fatigue female follicular Follicular lymphoma Formal highlight hospitalised Ibrutinib Imdevimab immune evasion Immunotherapy increased risk individuals Infection Inflammation lack lymphoma malaise male monoclonal antibody monoclonal antibody combination nasopharyngeal swabs neutralisation omicron outcome Passive immunisation Patient patients persistent persistent infection Primary and secondary immunodeficiency raised REGN-CoV2 Remdesivir Ronapreve (REGN-COV2) SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 variant SARS-CoV-2 variants secondary antibody secure Sequence analysis spike variant suffered sustained therapeutic therapy treated Treatment variants variants of concern Viral viral clearance viral evolution virological clearance with COVID-19 withdrawn [DOI] 10.1186/s12941-021-00491-2 PMC 바로가기 [Article Type] Case Reports
Bioinformatics and in-silico findings reveal medical features and pharmacological targets of biochanin A against colorectal cancer and COVID-19생물 정보학 및 실리코 내 발견은 결장 직장암 및 Covid-19에 대한 바이오 카닌 A의 의학적 특징과 약리학 적 목표를 보여줍니다.Research Article Published on 2021-12-232022-09-01 Journal: Bioengineered [Category] 유전자 메커니즘, 진단, 치료제, [키워드] addition Analysis applied approach biochanin a bioinformatics biological function Cancer patients CCND1 cell proliferation Chronic diseases Clinical use Cluster Colorectal cancer combination therapy COVID-19 COVID-19 infection COVID-19 pandemic COVID-19 vaccine COVID-19 vaccines cytokine receptor demonstrated Effect effective EGFR feature functional gene cluster IL1A IL2 IL6R immune response in-silico Interaction interleukin-6 involved JAK-STAT signaling pathway lack Mortality network pharmacology pathology Pathway analysis Patient patients pharmaceutical target pharmacological target PI3K PPARG receptor Side effect STAT therapeutic option Treatment [DOI] 10.1080/21655979.2021.2005876 PMC 바로가기 [Article Type] Research Article
Bioinformatics and in-silico findings reveal medical features and pharmacological targets of biochanin A against colorectal cancer and COVID-19Research Article Published on 2021-12-232022-10-27 Journal: Bioengineered [Category] COVID-19, [키워드] addition Analysis applied approach biochanin a bioinformatics biological function Cancer patients CCND1 cell proliferation Chronic diseases Clinical use Cluster Colorectal cancer combination therapy COVID-19 COVID-19 infection COVID-19 pandemic COVID-19 vaccine demonstrated Effect effective EGFR feature functional gene cluster IL1A IL2 IL6R immune response in-silico Interaction interleukin-6 involved JAK-STAT signaling pathway lack Mortality network pharmacology pathology Pathway analysis Patient patients pharmaceutical target pharmacological target PPARG receptor Side effect therapeutic option Treatment [DOI] 10.1080/21655979.2021.2005876 PMC 바로가기 [Article Type] Research Article